Neurofilament light chain levels indicate acute axonal damage under bortezomib treatment.
Cebulla N, Schirmer D, Runau E, Flamm L, Gommersbach S, Stengel H, Zhou X, Einsele H, Reinhold AK, Rogalla von Bieberstein B, Zeller D, Rittner H, Kortüm KM, Sommer C.
Cebulla N, et al. Among authors: zeller d.
J Neurol. 2023 Jun;270(6):2997-3007. doi: 10.1007/s00415-023-11624-2. Epub 2023 Feb 18.
J Neurol. 2023.
PMID: 36802032
Free PMC article.
Clinical Trial.